Bioactive peptides and proteins as alternative antiplatelet drugs.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Bioactive peptides and proteins as alternative antiplatelet drugs.
- Published In:
- Medicinal research reviews, 39(6), 2153-2171 (2019)
- Authors:
- Rengasamy, Kannan R R, Khan, Haroon, Ahmad, Imad, Lobine, Devina, Mahomoodally, Fawzi, Suroowan, Shanoo, Hassan, Sherif T S, Xu, Suowen, Patel, Seema, Daglia, Maria, Nabavi, Seyed Mohammad, Pandian, Shunmugiah Karutha
- Database ID:
- RPEP-04447
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04447APA
Rengasamy, Kannan R R; Khan, Haroon; Ahmad, Imad; Lobine, Devina; Mahomoodally, Fawzi; Suroowan, Shanoo; Hassan, Sherif T S; Xu, Suowen; Patel, Seema; Daglia, Maria; Nabavi, Seyed Mohammad; Pandian, Shunmugiah Karutha. (2019). Bioactive peptides and proteins as alternative antiplatelet drugs.. Medicinal research reviews, 39(6), 2153-2171. https://doi.org/10.1002/med.21579
MLA
Rengasamy, Kannan R R, et al. "Bioactive peptides and proteins as alternative antiplatelet drugs.." Medicinal research reviews, 2019. https://doi.org/10.1002/med.21579
RethinkPeptides
RethinkPeptides Research Database. "Bioactive peptides and proteins as alternative antiplatelet ..." RPEP-04447. Retrieved from https://rethinkpeptides.com/research/rengasamy-2019-bioactive-peptides-and-proteins
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.